Understanding urogenital biofilms and potential impact of probiotics.
Reid
G
G
Lawson Health Research Institute, St. Joseph's Health Centre, and Departments of Microbiology and Immunology, and Surgery, University of Western Ontario, London, Ontario N6A 4V2, Canada.
Heinemann
C
C
Howard
J
J
Gardiner
G
G
Gan
B S
BS
D001419:Bacteria / Q000235:genetics / Q000302:isolation & purification; D001424:Bacterial Infections / Q000382:microbiology / Q000517:prevention & control; D018441:Biofilms; D015342:DNA Probes; D005260:Female; D052776:Female Urogenital Diseases / Q000382:microbiology / Q000517:prevention & control; D005840:Gentian Violet; D006801:Humans; D018613:Microscopy, Confocal; D009181:Mycoses / Q000382:microbiology / Q000517:prevention & control; D010619:Phenazines; D019936:Probiotics; D015398:Signal Transduction; D014566:Urogenital System / Q000382:microbiology*; D015003:Yeasts / Q000235:genetics / Q000302:isolation & purification
D015342:DNA Probes; C035863:Gram's stain; D010619:Phenazines; D005840:Gentian Violet